Synergistic effects of simvastatin and bone marrow-derived mesenchymal stem cells on hepatic fibrosis
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 497 (1) , 264-271
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education (2016R1A6A3A11932575)
- Ministry of Health and Welfare (HI15C2364, HI17C1365)
- Korea Health Industry Development Institute
- National Research Foundation of Korea
This publication has 18 references indexed in Scilit:
- Statins and stem cell modulationAgeing Research Reviews, 2013
- Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosisHepatology, 2012
- Statins as modulators of colon cancer cells induced cytokine secretion by human PBMCVascular Pharmacology, 2011
- Haemodynamic evaluation by Doppler ultrasonography in patients with portal hypertension: a reviewLiver International, 2010
- Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor β1-mediated activation of intestinal fibroblastsBritish Journal of Surgery, 2009
- Computer-assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient #Hepatology, 2009
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Smad3: A Key Player in Pathogenetic Mechanisms Dependent on TGF‐βAnnals of the New York Academy of Sciences, 2003
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Proliferation, differentiation, and protein synthesis of human osteoblast‐like cells (MG63) cultured on previously used titanium surfacesClinical Oral Implants Research, 1996